The third edition of the CaixaImpulse, a programme run by the Banking Foundation La Caixa and Caixa Capital Risc that supports the development of bio-health projects, is to fund an immunotherapy pr
Latest news
-
CaixaImpulse funds an IRB Barcelona immunotherapy project for head and neck cancers -
Towards a deeper understanding of genome regulation -
Researchers at IRB Barcelona discover a crucial gene involved in the development of the placenta -
100 young students set to experience the Barcelona International Youth Science Challenge (BIYSC)
News
18 Jul 2017
Translation regulation—the process by which the amount of protein synthesized from its messenger RNA (mRNA) is controlled—is a crucial step in establishing the degree of gene expression during even
17 Jul 2017
The placenta, a transient organ that links the developing embryo to its mother, is responsible for nutrient, waste and gas exchange between the foetus and the mother.
10 Jul 2017
Today marks the start of the second edition of the Barcelona International Youth Science Challenge (BIYSC), aimed at stimulating scientific talent am
Media mentions
24 Jul 2017
The scientists from Madrid who will change the world
El Mundo
IRB Barcelona PhD student Marcos Fernández is one of three researchers featured in the article published today in El Mundo, following Friday's ceremony in Madrid, where 68 young scientists received their "la Caixa" doctoral fellowships.
18 Jul 2017
“Bee venom to treat central nervous system diseases”
Valencia en la Onda
In an interview on the programme “Valencia en la Onda”, presented by Mª Paz Fernández on Radio Onda Cero, Meritxell Teixidó, research associate at IRB Barcelona, talks about his research at the Design, Synthesis and Structure of Peptides and Proteins Laboratory.
17 Jul 2017
"Wasp venom in cancer therapy"
24Hours Naija News
The Nigerian website "24Hours Naija News" devotes a report to the use of insects such as termites and grasshoppers in the treatment of cancer, diabetes, rheumatoid arthritis or Human Immuno-deficiency Virus (HIV).
Laura Boulan
PhD Student
«I discovered that the bantam molecule drives the transition from larva to pupa, the phase analogous to human adolescence.»
More info about this news here.
Eduard Batlle
Group Leader
Group: Colorectal cancer laboratory
«We need to look at the soil, not at the seed. TGF-beta is the fertiliser that changes the earth in which the tumour seed grows.»
More info about this news here.
Laura Nevola
Research Associate
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Meritxell Teixidó
Research Associate
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
Felice Alessio Bava
former PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.
Lara Barrio
Postdoctoral Fellow
“From our study in Drosophila flies we can deduce that it would be particularly interesting to address vertebrates and analyse the participation of p53 in diabetes and obesity”
More on this news here
Jalaj Gupta
Postdoctoral Fellow
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
Photo gallery
Excess muscle glycogen in mice impairs endurance exercise performance
Excess muscle glycogen in mice impairs endurance exercise performance
A small group of neurons modulates the amount of insulin that the pancreas must produce
The loss of protein Dnmt3a increases the number of carcinogen-induced squamous tumours
A genome-editing strategy to study cancer stem cells in human tumours
A genome-editing strategy to study cancer stem cells in human tumours
Scientists discover how the cell stops growing in response to lack of nutrients
Researchers create viruses to selectively attack tumor cells
Researchers create viruses to selectively attack tumor cells
New research front to tackle Friedreich’s Ataxia
Contact
Quick facts about IRB
Quick facts
IRB Barcelona has been awarded the "HR Excellence in Research" logo. This recognition reflects the commitment of the Institute to continuously improving its human resources policies in line with the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers. The award confirms the efforts of the Institute to ensure fair and transparent recruitment and appraisal procedures. Click here for more information.
IRB Barcelona is home to nearly 450 research, technical and support staff from 35 countries who share the common goal of contributing to the advancement of the biomedical sciences through investigator–driven research, and improving quality of life by applying advances in this field.
The convergence of biology, chemistry, and structural and computational biology is unique at IRB Barcelona and opens a strategic window to gain insight into basic molecular processes in health and disease.
Research is conducted by 23 groups organized into 5 interdisciplinary programmes. Each programme includes a diverse faculty of researchers with overlapping scientific interests. The research areas have been structured to be highly interactive, fostering multidisciplinarity by combining modern molecular biology, classical genetics, biochemistry, structural biology, bioinformatics, systems biology, advanced microscopy, and genomic and proteomic approaches.
Our Board of Trustees comprises members of the Catalan Government (from the Department of Economy and Competitivity and the Department of Health), the University of Barcelona, a representative from the BBVA Foundation as well as internationally renowned scientists.